bpc-157 mitochondrial function evidence Conventional Antiarrhythmics Class I–IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias The Truth About BPC 157
Description
Joo NS, Irokawa T, Wu JV, Robbins RC, Whyte RI, Wine JJ
Faster IV NAD+ rates are the most commonly reported driver of acute side effects
That is an incredibly small injection volume, less than 0.4 mL
Eat a meal and drink plenty of water before your injection to stay nourished and hydrated, which can help prevent lightheadedness and support absorption
